- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02417584
Efficacy of PAP Therapy on Blood Pressure
April 14, 2015 updated by: Izolde Bouloukaki, University of Crete
The Role of Compliance With Positive Airway Pressure Use on Blood Pressure in Patients With Obstructive Sleep Apnea
The aim of the study was to determine the long term effects of compliance with positive airway pressure therapy on blood pressure in both hypertensive and normotensive patients with obstructive sleep apnoea hypopnoea syndrome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Scientific data about the causal role of obstructive sleep apnoea hypopnoea syndrome (OSAHS) in the development of systemic hypertension and the effects of positive airway pressure (PAP) treatment on blood pressure (BP) control are continuously increasing; however they are controversial.
We aimed to determine the long term effects of compliance with PAP therapy on BP in both hypertensive and normotensive patients with OSAHS.
Study Type
Interventional
Enrollment (Actual)
1168
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heraklion, Greece, 71110
- Sleep Disorders Center, Department of Thoracic Medicine, University of Crete,
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- newly diagnosed OSAHS by polysomnography according to standard criteria
- no history of previous PAP therapy
- normotensive and hypertensive patients
- an above-elementary school education.
Exclusion Criteria:
- refusal to participate
- refusal of PAP therapy
- secondary hypertension
- central sleep apnea syndromes
- obesity hypoventilation syndrome
- restrictive ventilator syndromes
- history of established cardiovascular disease
- severe congestive heart failure
- a history of life-threatening arrhythmias
- severe cardiomyopathy
- significant chronic kidney disease
- long-term oxygen therapy
- family or personal history of mental illness
- drug or alcohol abuse
- severe cognitive impairment
- concurrent oncological diseases
- need for chronic use of medication that may affect BP levels
- pregnancy
- history of narcolepsy or restless leg syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: positive airway pressure (PAP)
Treatment with positive airway pressure (PAP)
|
Positive Airway Pressure (PAP) is a non-invasive machine providing air pressure f to prevent the collapse of the oropharyngeal walls and the obstruction of airflow during sleep, which occurs in obstructive sleep apnea hypopnea syndrome.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
drop in blood pressure
Time Frame: two years
|
two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
April 11, 2015
First Submitted That Met QC Criteria
April 14, 2015
First Posted (Estimate)
April 15, 2015
Study Record Updates
Last Update Posted (Estimate)
April 15, 2015
Last Update Submitted That Met QC Criteria
April 14, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PAPBP-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnoea
-
Papworth Hospital NHS Foundation TrustIceni Labs Ltd, Warwickshire, United KingdomCompletedObstructive Sleep Apnoea | Sleep ApnoeaUnited Kingdom
-
Heart and Diabetes Center North-Rhine WestfaliaCompletedObstructive Sleep Apnoea | Cheyne Stokes Respiration | Central Sleep ApnoeaGermany
-
University of ZurichCompletedObstructive Sleep ApnoeaSwitzerland
-
ResMedCompletedObstructive Sleep Apnoea (OSA)Australia
-
ResMedCompleted
-
University of British ColumbiaCompleted
-
Air Liquide Santé InternationalClinactRecruitingObstructive Sleep Apnoea Syndrome (OSAS)Portugal
-
University of MalayaUnknownObstructive Sleep ApnoeaMalaysia
-
Wenzhou Medical UniversityCompletedObstructive Sleep ApnoeaChina
-
Chinese University of Hong KongCompleted
Clinical Trials on positive airway pressure (PAP)
-
University of CreteCompletedObesity Hypoventilation Syndrome
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | PreeclampsiaUnited States
-
ResMedSingapore General HospitalNot yet recruitingObstructive Sleep Apnea
-
ResMedUnknownObstructive Sleep Apnea (OSA)Australia
-
ResMedCompletedObstructive Sleep Apnea (OSA)United States, Australia
-
VA Office of Research and DevelopmentRecruitingObstructive Sleep Apnea | Substance Use Disorder | Post Traumatic Stress Disorder | Residential Treatment ProgramUnited States
-
Philips RespironicsCompletedObstructive Sleep Apnea | Cheyne-Stokes Respiration | Sleep Apnea CentralUnited States
-
Dr John KimoffCanadian Institutes of Health Research (CIHR); ResMed Canada Inc.CompletedSleep Apnea, Obstructive | Hypertensive Disorder of PregnancyCanada
-
Hadassah Medical OrganizationUniversity of RochesterUnknownPregnancy | Sleep Apnea
-
Mayo ClinicResMed Foundation; Medtronic Xomed, Inc.CompletedSleep Apnea, ObstructiveUnited States